ロード中...
Therapeutic Potential of Lebrikizumab in the Treatment of Atopic Dermatitis
BACKGROUND: Atopic dermatitis (AD) is a chronic, relapsing skin condition with a wide disease spectrum. Moderate-to-severe cases often need systemic treatment. Conventional immunosuppressants have extensive side effect profiles and require close monitoring. In recent decades, there has been increasi...
保存先:
| 出版年: | J Asthma Allergy |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7023853/ https://ncbi.nlm.nih.gov/pubmed/32104006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S211032 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|